News stories about Tenet Healthcare (NYSE:THC) have trended positive recently, according to Accern. The research group identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Tenet Healthcare earned a news impact score of 0.26 on Accern’s scale. Accern also gave press coverage about the company an impact score of 44.1604721825109 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

Shares of Tenet Healthcare (NYSE:THC) opened at $14.34 on Friday. Tenet Healthcare has a 1-year low of $12.25 and a 1-year high of $22.72. The company has a quick ratio of 1.21, a current ratio of 1.28 and a debt-to-equity ratio of 21.21.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Monday, November 6th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.23. The firm had revenue of $4.59 billion during the quarter, compared to the consensus estimate of $4.94 billion. Tenet Healthcare had a negative return on equity of 5.61% and a negative net margin of 2.85%. The business’s revenue for the quarter was down 5.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.16 EPS. equities research analysts predict that Tenet Healthcare will post 0.69 earnings per share for the current fiscal year.

THC has been the subject of several recent research reports. Mizuho restated a “neutral” rating and set a $14.00 price objective on shares of Tenet Healthcare in a report on Thursday, September 14th. J P Morgan Chase & Co downgraded Tenet Healthcare from a “neutral” rating to an “underweight” rating and set a $15.00 price target for the company. in a report on Thursday. Jefferies Group reiterated a “buy” rating and set a $24.00 price target on shares of Tenet Healthcare in a report on Thursday, September 21st. Royal Bank of Canada decreased their price target on Tenet Healthcare from $19.00 to $17.00 and set a “sector perform” rating for the company in a report on Monday, November 13th. Finally, Leerink Swann reiterated an “outperform” rating and set a $30.00 price target (up previously from $23.00) on shares of Tenet Healthcare in a report on Sunday, August 20th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $18.73.

COPYRIGHT VIOLATION WARNING: This piece was reported by Watch List News and is the property of of Watch List News. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at

About Tenet Healthcare

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Insider Buying and Selling by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with's FREE daily email newsletter.